A method for immunising a subject against serogroup X meningococcus by administering a vaccine comprising one, two or all three of: (i) a meningococcal fHbp antigen (ii) a meningococcal NHBA antigen and/or (iii) a meningococcal NadA antigen. The vaccine may also include meningococcal outer membrane vesicles.